Biopharma Stock Powers Higher on Study Update

Theralase Technologies Inc. (TSXV:TLT), a biopharma stock, shot up after announcing results from its Phase Ib Non-Muscle Invasive Bladder Cancer clinical study

Sean Mason | November 8, 2018 | SmallCapPower

A potential cancer treatment breakthrough produced healthy gains for a biopharma stock Thursday. Here’s some small stocks making big moves on Thursday, November 8, 2018 (as of 4 pm EST):

Theralase Technologies Inc. (TSXV:TLT), a biopharma stock, surged 21% to $0.35 on Thursday after announcing that patient five, who enrolled and was treated in the recently-completed Phase Ib Non-Muscle Invasive Bladder Cancer clinical study using light-activated Photo Dynamic Compounds and their associated drug formulations, demonstrated no tumour recurrence or presence of disease at the 90 day, 180 day, or 270 day clinical and cystoscopy assessment post treatment.

Win Big With Our Small Cap Picks


As well, shares of Freshii Inc. (TSX:FRII) sank 33% to $2.65 as the health and wellness food retailer said it has decided to withdraw its financial outlook through fiscal 2019.

Canada Jetlines Ltd. (TSXV:JET), meanwhile, reported that it intends to offer ultra-low fare service to the Montréal region from Aéroport Montréal Saint-Hubert Longueuil. Canada Jetlines stock moved up 19% to $0.68 following the announcement.

Finally, ProntoForms Corporation (TSXV:PFM) shares gained 9% to $0.37 after the provider of smart mobile forms for enterprise announced that its recurring revenue in Q3 2018 increased 24% to $2,780,814.

See more Small and Micro Cap Market Movers Daily from Sean Mason. Tomorrow’s big stock market winners could be found here today!

Hi, did you know SmallCapPower accepts blog submissions? You can contact me here

Disclosure: Neither the author nor his family own shares in any of the companies mentioned above.

To read our full disclosure, please click on the button below: